Effects of Immunomodulators on the Pharmacokinetics and Efficacy of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT-SC Induction and Maintenance StudiesOmoniyi J. Adedokun, William J. Sandborn, Colleen Marano et al.|The American Journal of Gastroenterology|2013Cited by 4